</center>
ÅäÅä½ÎÀÌÆ®<- ¹Ù·Î°¡±â MONTREAL--( / )--Immervision, the Montreal-based leader in wide-angle intelligent vision, today announced it has received an award from the Defense Innovation Unit (DIU), part of the U.S. Department of Defense (DoD) for a Blue UAS Framework effort.
The Immervision InnovationLab team is developing a wide-angle computer vision camera for small Unmanned Aerial Systems (sUAS), enabling advanced low-light vision for Blue UAS Framework effort which provides affordable, trusted, high performing, and interoperable UAS drone technologies for commercial and defense applications.
¡°We are honored that the Defense Innovation Unit has chosen Immervision¡¯s InnovationLab to create this innovative wide angle computer vision camera optimized for drones in low light vision and autonomous flight,¡± said Alessandro Gasparini, Executive Vice President, Operations and Chief Commercial Officer of Immervision. ¡°Immervision¡¯s technology has been widely adopted in aerospace, surveillance systems and for consumer electronics for over 20 years. We look forward to working with the DIU to deliver secured, highly advanced sUAS camera for the U.S. Department of Defense¡¯s applications.¡±
Immervision has been involved in vision system designs for highly complex applications such as aerospace cameras, stratospheric balloons as well as commercial applications from video surveillance, action cameras, IoT to mobile phones. Immervision¡¯s technology provides wide-angle field with edge-to-edge augmented resolution, controlled distortion, and withstands extreme conditions.
About Immervision
Immervision enables intelligent vision in any device. Our Deep Seeing technology and renowned experts in wide-angle optical design and image processing enable smart devices with superhuman eyes to capture high quality visual and contextual data. We invent, customize and license wide-angle lenses and imaging software technology for AI, machine vision and user applications, from capture to display, in the mobile, automotive, robotics, security, and other industrial and consumer product industries.
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry¡¯s largest press release distribution network
TOKYO--( / )--On March 31, Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) released KANEKA RT-PCR Kit ¡°SARS-CoV-2 (Omicron/Delta) ver.2¡±, a real-time PCR HAPPYLOTTO test kit capable of simultaneously detecting the Omicron (BA.1), ¡°Stealth¡± Omicron (BA.2), and Delta variants of COVID-19. The kit has a suggested retail avril2day TOKYO--(of 121,000 yen (for 100 tests), including tax.
This test kit uses a proprietary reagent developed ¼½½º½ºÅ丮 ThisKaneka's molecular testing-related technologies to detect the presence of three variants with a single PCR test. This is expected to help reduce the burden placed HAPPYLOTTO ÀÏȸ¿ë¾ËÄÝ¼Ø by testing and to assist with selecting the best suitable drugs and treatment approaches for each variant in clinical settings.
Kaneka has already released the KANEKA Direct RT-PCR Kit SARS-CoV-2, an in-vitro diagnostic reagent that uses Kaneka's original sample processing technology to produce test results in less than an hour, KANEKA RT-PCR Kit ¡°SARS-CoV-2 (L452R/E484Q/E484K/N501Y)¡±, which can detect HAPPYLOTTO ³Ãµ¿¼ö¼ú±â four variants simultaneously, and KANEKA RT-PCR Kit ¡°SARS-CoV-2 (Omicron/Delta)¡± which can detect the Delta and Omicron variants of COVID-19. These Kaneka products ÅäÅä½ÎÀÌÆ® Á·Àú»ç¸¶±Í are being used at major sporting events and for pre-travel PCR testing, as well as in medical facilities and testing centers. These products make it possible to quickly test large numbers of StudioR3 Kaneka
Kaneka is taking a HAPPYLOTTO wide range of measures to combat COVID-19. These include the launching of the ¡°Infection Initiative Team,¡± which conducts research and development regarding infection control measures including COVID-19, expanding our ÅäÅä½ÎÀÌÆ® Ǫ¸£¼³Å¸¹Î lineup of PCR test kits, performing contract manufacturing of DNA vaccine APIs and intermediates, developing antibody drugs, supplying PCR testing reagents and testing kits, and shipping vaccine using HAPPYLOTTO ¼Òµ¶¿ë¿¡Åº¿ÃÆÇ¸Å temperature-controlled packages.
(To HAPPYLOTTO ºñ½Å¼¼°æÂî¶ó½Ã view the º¸¹Í½º (Toplease visit )
These refer to ³×Åä´åÄÄ Theseof the amino acids in viral spike proteins. The names are based on the mutation. HAPPYLOTTO ü¿Â°è In the E484A mutation, the spike protein has changed from E (glutamine acid) to A HAPPYLOTTO ¹ÙÀ̵¦½º (alanine). ÅäÅä½ÎÀÌÆ® ¹Ì¶õ´ÙĿȺ¸ In the N856K mutation, the change was from N (asparagine) to HAPPYLOTTO LS7000 K (lysine). In the L452R mutation, it was from L (lysine) to R (arginine).
Inquiry Form:Korea Newswire distributes your news across every media channels HAPPYLOTTO ÆÐ¹Ð¸®°¡¶¹´ÙÀÌÈ¿¸®³ëÃâ through the industry¡¯s largest press release distribution network